ARAna Paula Toledo Del Rio

Ana Paula Toledo Del Rio

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Paula Toledo Del Rio has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuro-Behçet’s disease: a pictorial essay

    by Carlos Eduardo Garcez Teixeira, Carlos Roberto Martins Junior, Renan Denadai Turci, Gustavo Yamada, Ana Paula Toledo Del Rio, Zoraida Sachetto, Fabiano Reis

    Neuro-Behçet’s disease (NBD) is a rare but serious manifestation of Behçet’s disease, categorized into parenchymal and non-parenchymal forms, each with distinct clinical and imaging characteristics. Parenchymal NBD primarily af-fects the brainstem, basal ganglia, and diencephalon. On magnetic resonance imaging (MRI), acute or subacute lesions appear hyperintense on T2-weighted or fluid-attenuated inversion recovery sequences and isointense to hypointense on T1-weighted sequences, whereas chronic lesions may present as asymmetrical atrophic changes. Non-parenchy-mal NBD may present as cerebral venous thrombosis, arterial involvement, and meningeal inflammation. Here, we provide a pictorial essay on MRI central nervous system studies, mostly following an international consensus classifi-cation of NBD. Although NBD is rare, recognizing its characteristic imaging features is crucial for early diagnosis and treatment, potentially improving prognosis and reducing long-term neurological complications.

  • Open Access

    The burden of mental health issues in Behçet’s disease: implications for patient quality of life

    by Carlos Eduardo Garcez Teixeira, Fabiano Reis, Marília Paula Souza dos Santos, Marina Ferreira Simões, Ana Paula Toledo Del Rio, Ibsen Bellini Coimbra, Alisson Pugliesi, Eduardo de Paiva Magalhães, Zoraida Sachetto

    Depression and anxiety are among the most prevalent mental health conditions in Brazil. Both are associated with poor quality of life (HRQoL) and challenges in disease management for chronic illnesses, including Behçet's disease (BD). This study aimed to evaluate depression, anxiety, and HRQoL in BD patients from a non-endemic area. This case-control study included adult BD patients from Brazilian tertiary center and healthy controls (HC). All patients fulfilled the ISG and ICBD diagnostic criteria. Depression, anxiety and quality of life were assessed using BDI, HADS, SF-36, and physical capacity with the HAQ. We enrolled 58 BD patients (60% female, median age 48.5) and 96 HC (74% female, median age 40.5). High rates of depression and anxiety were observed in BD patients, correlating with disease activity, younger age, absence of a partner, shorter disease duration, and lower income. BD patients showed significant HRQoL restrictions, particularly in physical and emotional roles, compared to HC. Longer disease duration correlated with better HRQoL. High rates of depression and anxiety were observed in BD patients, negatively impacting HRQoL, particularly in those with higher disease activity. Further study and clinical attention are warranted to enhance patient care and outcomes.


  • Open Access

    Impaired repair properties of endothelial colony‐forming cells in patients with granulomatosis with polyangiitis

    by Ana Paula Toledo Del Rio, Jéssica O Frade‐Guanaes, Stephanie Ospina‐Prieto, Bruno K L Duarte, Manoel Barros Bertolo, Margareth C Ozelo, Zoraida Sachetto

    In patients with ANCA‐associated vasculitis, interactions between neutrophils and endothelial cells cause endothelial damage and imbalance. Endothelial colony‐forming cells (ECFCs) represent a cellular population of the endothelial lineage with proliferative capacity and vasoreparative properties. This study aimed to evaluate the angiogenic capacity of ECFCs of patients with granulomatosis with polyangiitis (GPA). The ECFCs of 13 patients with PR3‐positive GPA and 14 healthy controls were isolated and characterized using fluorescence‐activated cell sorting, capillary tube formation measurement, scratching assays and migration assays with and without plasma stimulation. Furthermore, three patients with active disease underwent post‐treatment recollection of ECFCs for longitudinal evaluation. The ECFCs from the patients and controls showed similar capillary structure formation. However, the ECFCs from the patients with inactive GPA exhibited early losses of angiogenic capacity. Impairments in the migration capacities of the ECFCs were also observed in patients with GPA and controls (12th h, p = 0.05). Incubation of ECFCs from patients with GPA in remission with plasma from healthy controls significantly decreased migration capacity (p = 0.0001). Longitudinal analysis revealed that treatment significantly lowered ECFC migration rates. This study revealed that ECFCs from the patients with PR3‐positive GPA in remission demonstrated early losses of tube formation and reduced migration capacity compared to those of the healthy controls, suggesting impairment of endothelial function.


  • Open Access

    HLA Markers for Poor Prognosis in Systemic Sclerosis Brazilian Patients

    by Ana Paula Toledo Del Rio, Zoraida Sachetto, Percival Degrava Sampaio-Barros, João Francisco Marques-Neto, Ana Carolina Santos Londe, Manoel Barros Bertolo

    Objectives. The aim of this study was to evaluate human leukocyte antigen (HLA) involvement in the disease expression and poor prognostic clinical features (pulmonary fibrosis and pulmonary arterial hypertension) in patients diagnosed with systemic sclerosis (SSc) in a multiethnic population.Methods. SSc patients followed up between 2008 and 2011 were included, and clinical data were obtained through records review. Molecular HLA typing was performed (polymerase chain reaction amplification technique using specific primer sequences). The statistical analysis involved Fisher’s exact test and Pearson's corrected chi-square test.P  values≤0.05were considered significant. The delta method was used to estimate the variance of the prevalence ratio (PR).Results. A total of 141 patients (120 women and 21 men) with SSc were studied, including 33.3% with diffuse cutaneous SSc (dcSSc), 62.4% with limited cutaneous SSc (lcSSc), and 4.3% with sine scleroderma. Pulmonary fibrosis was present in 61 patients (43.3%), and the HLA-A*30 and DQB1*04 alleles were related to susceptibility. In contrast, the HLA-DRB1*01 and DQB1*05 alleles were protective. Pulmonary arterial hypertension was diagnosed in 19 patients (13.5%) and was associated with HLA-B*35 and C*04; in contrast, C*03 seemed to be protective.Conclusions. Our current study documents the association of some classes I and II HLA alleles with the most severe clinical manifestations in a multiethnic case series. Our findings differed slightly from the previous data in other populations.